Jan Garfinkle

Verified

Chief Executive Officer at Arboretum VenturesListed on SEC Form ADVAnn Arbor, United States

Claim this profile

Cold

Check Size

Not yet known

Reliability Score

🎯100% of deals in Healthcare

Investment Timeline

NeuMoDx Molecular

Board seat (SEC Form D)Source

Since Mar 2014

Company last raised May 2018

Portfolio Breakdown

By Sector

Healthcare1 deal · 100%

By Stage

1 tracked deal1 sector · 0 stages

Deal Velocity

Avg Deals / Year

1.0

Avg Deal Size

Unknown

Largest Deal

NeuMoDx Molecular

Unknown

YoY Trend

Steady

Deals Per Year

1 total deal tracked2014–2014

Investment Activity Map

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

2014

Less

Current Fund Status

Fund Name

Arboretum Ventures 1-A, LLC

Reported Size